PTNT — PALATIN TECHNOLOGIES INC
—
·
Health Care ·
Pharmaceuticals ·
CIK 911216 ·
Last close
$26.84
Market Cap
—
52W High
$26.84
52W Low
$25.28
ADV30
3,938
Next earnings
—
No quarterly fundamentals indexed for this ticker.
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| LLY | ELI LILLY & Co | $949.47B | $1064.74 | — |
| JNJ | JOHNSON & JOHNSON | $554.09B | $230.18 | — |
| ABBV | AbbVie Inc. | $376.54B | $213.12 | — |
| MRK | Merck & Co., Inc. | $295.69B | $119.72 | — |
| AZN | ASTRAZENECA PLC | $290.30B | $187.19 | — |
News headlines (Yahoo Finance, 1h cache)
Palatin Technologies Inc (PTN) Q1 2026 Earnings Call Highlights: Strategic Collaborations and ...
2025-11-13 23:01 · Yahoo
ObesityWeek 2025: Breakthrough Results Reshaping the Obesity Market Landscape | DelveInsight
2025-11-13 22:31 · Yahoo
Palatin Reports First Quarter Fiscal Year 2026 Financial Results and Provides Corporate Update
2025-11-13 12:30 · Yahoo
Palatin Technologies Announces Closing of Upsized $18.2 Million Public Offering with the Full Exercise of the Underwriters' Over-Allotment Option
2025-11-12 17:15 · Yahoo
Palatin Presents Data at ObesityWeek® 2025 Highlighting Promise of Melanocortin-Based Therapies for Obesity
2025-11-06 13:00 · Yahoo
Palatin Technologies Announces Pricing of Upsized $15.8 Million Public Offering
2025-11-06 12:30 · Yahoo
Palatin Earns €5.5 Million ($6.5 Million) Milestone Payment in Retinal Disease Collaboration with Boehringer Ingelheim
2025-09-22 11:30 · Yahoo
Boehringer Ingelheim marks retinal disease push with $327m licensing deal
2025-08-18 15:58 · Yahoo
Boehringer Ingelheim and Palatin Technologies to develop potential first-in-class melanocortin receptor targeted treatment for patients with retinal diseases
2025-08-18 12:05 · Yahoo
Palatin Announces 1-for-50 Reverse Stock Split
2025-08-08 20:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.